Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell disease

6 Oct 2023

Abstract excerpt

INTRODUCTION: Hematopoietic stem cell transplant (HSCT) is the only readily available curative option for sickle cell disease (SCD). Cure rates following human leukocyte antigen (HLA)-matched related donor HSCT with myeloablative or non-myeloablative conditioning are >90%. Alternative donor sources, including haploidentical donor and autologous with gene therapy, expand donor options but are limited by inferior...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood groups and transfusion
Share to Hematopoietic Stem Cell Transplantation
Share to Hemoglobinopathies and Related Disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37800996
DOI: 10.1080/17474086.2023.2268271

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcomes and long-term effects of hematopoietic stem cell transplant in sickle cell diseasePMID 37800996Read ↗

Stem cell transplantation in sickle cell disease: therapeutic potential and challenges facedSemantic proximity Read ↗

Update of hematopoietic cell transplantation for sickle cell diseaseSemantic proximity Read ↗

Outcomes of Hematopoietic Stem Cell Transplantation in children with Sickle Cell Disease: Does donor Sickle cell trait status matter?Semantic proximity Read ↗

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is nowSemantic proximity Read ↗

Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell DiseaseSemantic proximity Read ↗

Hematopoietic Cell Transplantation for Sickle Cell DiseaseSemantic proximity Read ↗

Advances in Sickle Cell Disease Treatment: A Comparative Review of Hematopoietic Stem Cell Transplantation and Gene Therapy (Casgevy and Lyfgenia)Semantic proximity Read ↗

Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editingSemantic proximity Read ↗

Sickle Cell DiseaseSemantic proximity Read ↗

Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell DiseaseSemantic proximity Read ↗

Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panelSemantic proximity Read ↗

End Organ Affection in Sickle Cell DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.